Anna Piskorz

7.0k total citations · 2 hit papers
34 papers, 2.7k citations indexed

About

Anna Piskorz is a scholar working on Cancer Research, Oncology and Reproductive Medicine. According to data from OpenAlex, Anna Piskorz has authored 34 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 12 papers in Oncology and 12 papers in Reproductive Medicine. Recurrent topics in Anna Piskorz's work include Cancer Genomics and Diagnostics (19 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cancer-related molecular mechanisms research (5 papers). Anna Piskorz is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cancer-related molecular mechanisms research (5 papers). Anna Piskorz collaborates with scholars based in United Kingdom, Poland and Canada. Anna Piskorz's co-authors include James D. Brenton, Nitzan Rosenfeld, Mercedes Jimenez‐Liñan, Muhammed Murtaza, Christine Parkinson, Davina Gale, Carlos Caldas, Dana W.Y. Tsui, Sarah‐Jane Dawson and Andrew P. May and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anna Piskorz

34 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

2012 975 citations Christine Parkinson, Davina Gale et al. profile →
EGFR-activated myofibroblasts promote metastasis of pancreatic cancer

2023 101 citations Wenlong Li, Priscilla S.W. Cheng et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Piskorz United Kingdom	17	1.6k	1.1k	1.0k	749	576	34	2.7k
Gavin Ha United States	22	1.6k 1.0×	1.7k 1.6×	951 0.9×	688 0.9×	167 0.3×	54	3.3k
Étienne Rouleau France	28	1.1k 0.7×	1.2k 1.2×	1.1k 1.0×	644 0.9×	168 0.3×	110	2.7k
Bedia A. Barkoh United States	25	1.2k 0.8×	1.1k 1.0×	667 0.7×	611 0.8×	112 0.2×	45	2.4k
Narciso Olvera United States	27	600 0.4×	1.1k 1.1×	634 0.6×	230 0.3×	942 1.6×	44	2.4k
Ruth Perets Israel	18	493 0.3×	914 0.9×	1.3k 1.3×	546 0.7×	613 1.1×	61	2.7k
Christine Parkinson United Kingdom	14	2.4k 1.5×	1.2k 1.1×	1.4k 1.4×	1.3k 1.7×	294 0.5×	29	3.3k
Laura J. Tafe United States	24	530 0.3×	667 0.6×	965 0.9×	1.0k 1.4×	194 0.3×	100	2.2k
Francesco Marass United Kingdom	12	1.6k 1.0×	848 0.8×	834 0.8×	861 1.1×	135 0.2×	20	2.1k
Sasinya N. Scott United States	19	689 0.4×	1.0k 1.0×	904 0.9×	586 0.8×	193 0.3×	29	2.2k

Countries citing papers authored by Anna Piskorz

Since Specialization

Citations

This map shows the geographic impact of Anna Piskorz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Piskorz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Piskorz more than expected).

Fields of papers citing papers by Anna Piskorz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Piskorz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Piskorz. The network helps show where Anna Piskorz may publish in the future.

Co-authorship network of co-authors of Anna Piskorz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Piskorz. A scholar is included among the top collaborators of Anna Piskorz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Piskorz. Anna Piskorz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García, María J., et al.. (2024). scAbsolute: measuring single-cell ploidy and replication status. Genome biology. 25(1). 62–62. 4 indexed citations

Li, Wenlong, Akanksha Anand, Priscilla S.W. Cheng, et al.. (2024). Protocol for the characterization of the pancreatic tumor microenvironment using organoid-derived mouse models and single-nuclei RNA sequencing. STAR Protocols. 5(3). 103203–103203. 2 indexed citations

Huhn, Oisín, Veronika Karlsson, Delia Hawkes, et al.. (2023). Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer Patients. Cancers. 15(13). 3362–3362. 11 indexed citations

Li, Wenlong, Priscilla S.W. Cheng, Akanksha Anand, et al.. (2023). EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell. 42(1). 101–118.e11. 101 indexed citations breakdown →

Vias, Maria, Lena Morrill Gavarró, Carolin M. Sauer, et al.. (2023). High-grade serous ovarian carcinoma organoids as models of chromosomal instability. eLife. 12. 20 indexed citations

Mirza, Hasan, Darren Ennis, Philip Smith, et al.. (2022). The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma. Clinical Cancer Research. 28(13). 2911–2922. 28 indexed citations

Macintyre, Geoff, Anna Piskorz, Edith Ross, et al.. (2021). FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections. JCO Clinical Cancer Informatics. 5(5). 176–186. 1 indexed citations

Wang, Linyuan, Anna Piskorz, Tjalling Bosse, et al.. (2021). Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies. International Journal of Gynecological Pathology. 41(1). 12–19. 12 indexed citations

Mittempergher, Lorenza, Anna Piskorz, Astrid J Bosma, et al.. (2020). Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene. PLoS ONE. 15(7). e0235766–e0235766. 2 indexed citations

10.

Montfort, Anne, Anna Piskorz, Anna Supernat, et al.. (2020). Combining measures of immune infiltration shows additive effect on survival prediction in high-grade serous ovarian carcinoma. British Journal of Cancer. 122(12). 1803–1810. 20 indexed citations

11.

Piskorz, Anna, et al.. (2019). Time management in the profession of nurse manager – a case study. SHILAP Revista de lepidopterología. 27(3-4). 189–196. 1 indexed citations

12.

Tsui, Dana W.Y., Heather Biggs, Sarah‐Jane Dawson, et al.. (2018). Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients. Journal of Molecular Diagnostics. 20(6). 883–892. 84 indexed citations

13.

Parkinson, Christine, Davina Gale, Anna Piskorz, et al.. (2016). Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study. PLoS Medicine. 13(12). e1002198–e1002198. 204 indexed citations

14.

Piskorz, Anna, Kevin Lin, Elaina Mann, et al.. (2016). Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high-grade serous carcinoma on the ARIEL2 trial.. Journal of Clinical Oncology. 34(15_suppl). 5549–5549. 13 indexed citations

15.

Lee, Sandra, Anna Piskorz, Cécile Le Page, et al.. (2015). Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma. International Journal of Gynecological Pathology. 35(3). 209–221. 25 indexed citations

16.

Kelemen, Linda E., James D. Brenton, Christine Parkinson, et al.. (2014). Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women. PLoS ONE. 9(5). e96542–e96542. 10 indexed citations

17.

Ratajska, Magdalena, Anna Piskorz, Izabela Brożek, et al.. (2011). Cancer predisposing BARD1 mutations in breast–ovarian cancer families. Breast Cancer Research and Treatment. 131(1). 89–97. 71 indexed citations

18.

Wasąg, Bartosz, Marek Niedoszytko, Anna Piskorz, et al.. (2011). Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis. Experimental Hematology. 39(8). 859–865.e2. 31 indexed citations

19.

Mital, Andrzej, Anna Piskorz, Krzysztof Lewandowski, et al.. (2011). A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib. European Journal Of Haematology. 86(6). 531–535. 38 indexed citations

20.

Piórecka, Beata, et al.. (2007). [Influence of nutrition on selected metabolic cardiovascular risk factors among female residents of Krakow].. PubMed. 58(1). 119–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact